CD46 Genetic Variability and HIV-1 Infection Susceptibility

No Thumbnail Available

Date

2021-11-01

Authors

Serrano-Risquez, Carmen
Omar, Mohamed
Amparo Gomez-Vidal, Maria
Miguel Real, Luis
Antonio Pineda, Juan
Rivero, Antonio
Rivero-Juarez, Antonio
Forthal, Donald
Marquez, Francisco J.
Lo Caputo, Sergio

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Mdpi
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

CD46 is the main receptor for complement protein C3 and plays an important role in adaptive immune responses. CD46 genetic variants are associated with susceptibility to several infectious and autoimmune diseases. Additionally, CD46 function can be subverted by HIV-1 to evade attack by complement, a strategy shared by viruses of other families. We sought to determine the association between CD46 gene variants and HIV-1 acquired through intravenous drug use (IDU) and sexual routes (n = 823). Study subjects were of European ancestry and were HIV-1 infected (n = 438) or exposed but seronegative (n = 387). Genotyping of the rs2796265 SNP located in the CD46 gene region was done by allele-specific real-time PCR. A meta-analysis merging IDU and sexual cohorts indicates that the minor genotype (CC) was associated with increased resistance to HIV-1 infection OR = 0.2, 95% CI (0.07-0.61), p = 0.004. The HIV-1-protective genotype is correlated with reduced CD46 expression and alterations in the ratio of CD46 mRNA splicing isoforms.

Description

MeSH Terms

DeCS Terms

CIE Terms

Keywords

HIV-1, HIV exposed seronegative, HESN, CD46, complement, Recombinant glycoprotein-120 vaccine, Complement regulatory proteins, Natural-resistance, Dendritic cells, Nitric-oxide, Receptor, Expression, Polymorphisms, Individuals, Association

Citation